Literature DB >> 21055842

Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.

Joaquim Bosch-Barrera, Ignacio Gil-Bazo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21055842     DOI： 10.1016/j.lungcan.2010.10.004

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  1 in total

1.  Clinical study of apatinib combined with EGFR-TKI in the treatment of chronic progression after EGFR-TKI treatment in non-small cell lung cancer (ChiCTR1800019185).

Authors:  Xin Li; Minghui Liu; Hongbing Zhang; Hongyu Liu; Jun Chen
Journal:  Thorac Cancer       Date:  2020-01-09       Impact factor: 3.500
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.